The leader in quality education and networking through//conferences, courses and custom training
Connect with IBC Life Sciences:LinkedIn iconTwitter iconFacebook iconRSS icon
EmailPrint

Find Another IBC Event

Circulating Tumors Cells as Biomarkers: Opportunities for Non-invasive Tumor Characterization and Patient Stratification in Oncology

CSS

April 24, 2012, 2:00-3:00 pm, EDT

Overview

Overview

Join us for a Free Webinar on April 24

Register Now

Space is limited.
Reserve your Webinar seat now at:
https://www1.gotomeeting.com/register/221846960

Biodesix
IBC Life Sciences

Circulating tumor cells (CTCs) likely derive from clones in the primary tumor, suggesting that they can be the support of all biological tests applying to the primary cells. The new device is a single-use and low-cost innovative technology to isolate tumor cells by size on a filter without requiring a large and expansive apparatus. The System is available for cytology, cell culture, and molecular biology.

  1. To isolate CTCs we need a tool. Once we have a reliable tool, we can address fundamental questions about clinical usefulness of CTCs.
    • Are CTCs representative of the primary tumor phenotypic and genotypic heterogeneity?
    • May CTCs characteristics be different from the primary tumor cells phenotype and genotype?
    • May CTCs harbor subpopulation of tumor initiating cells?
  2. Learn more about The ScreenCell© Cyto device for Cylogical Analysis of CirculatingTumor Cells
  3. Learn about: cytomorphology, Immunocytochemistry, FISH Assays, 3D telomeric profiles of CTC isolated with ScreenCell device, The ScreenCell© CC device for isolation of Live Cells and Cell Culture, ScreenCell© MB devices for molecular biology

Presenter:
Dr. Yvon Cayre, Professor, Department of Clinical Hematology, Hôpital Robert Debré

Dr. Yvon Cayre is currently a tenured professor of hematology at the Pierre and Marie Curie University and the clinical hematology department, at the Robert Debré hospital. He was Research Director at the French National Institute of Health (INSERM) from 1995 to 2007.

Title:

 

Circulating Tumors Cells as Biomarkers: Opportunities for Non-invasive Tumor Characterization and Patient Stratification in Oncology

Date:

 

Tuesday, April 24, 2012

Start:

 

2:00 pm (EDT)

End:

 

3:00 pm (EDT)

After registering you will receive a confirmation email containing information about joining the Webinar.

System Requirements
PC-based attendees
Required: Windows® 7, Vista, XP or 2003 Server

Macintosh®-based attendees
Mac OS® X 10.5 or newer